Skip to main content
Equibles

Summit Trail Advisors, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1698478 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$92,800
+$37,000 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 98 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Summit Trail Advisors, LLC holds $31,557,207 across 30 Biotechnology names. GALT ranks #29 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JAZZ
Jazz Pharmaceuticals plc
 25,428 $6,127,385
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 7,429 $3,690,207
3 RPRX
Royalty Pharma plc
 39,362 $2,207,027
4 REGN
Regeneron Pharmaceuticals, Inc.
 3,083 $1,922,373
5 MRNA
Moderna, Inc.
 24,030 $1,682,820
6 TECH
BIO-TECHNE Corp
 22,807 $1,611,314
7 INCY
Incyte Corp
 13,838 $1,568,675
8 RVMD
Revolution Medicines, Inc.
 7,559 $1,415,649

All Filings in GALT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,800 20,000
2026-03-31 $55,800 20,000
2025-12-31 $83,200 20,000
2025-09-30 $84,800 20,000
2025-06-30 $42,200 20,000
2024-09-30 $55,000 20,000
2024-06-30 $45,200 20,000
2024-03-31 $47,800 20,000
2023-12-31 $33,200 20,000
2023-09-30 $38,400 20,000
2023-06-30 $28,800 20,000
2022-09-30 $38,883 23,855
2022-06-30 $31,250 23,855
2022-03-31 $38,406 23,855